nitrates has been researched along with Cystic Fibrosis in 30 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " aeruginosa strains were isolated from cystic fibrosis patients and minimum inhibitory concentration of amikacin, tobramycin, and ciprofloxacin was determined against all the strains." | 4.31 | Determining effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of clinical strains of Pseudomonas aeruginosa in biofilm-inspired alginate encapsulates. ( Beigverdi, R; Emaneini, M; Halimi, S; Jabalameli, F; Siroosi, M, 2023) |
| " Inflammation was analysed using the measurement of nitric oxide, pH and concentration of nitrites, nitrates and isoprostane in the exhaled air condensate." | 3.75 | [Inflammation markers in the exhaled air of patients with bronchiectasis unassociated with cystic fibrosis]. ( Cortijo, J; de Diego Damiá, A; Fullana, J; León, M; Martínez-Moragón, E; Palop-Cervera, M, 2009) |
| " The systemic bioavailability of l-arginine for nitric oxide synthases, expressed as ratio of l-arginine/l-ornithine+lysine, remained unchanged." | 2.73 | Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients. ( Grasemann, C; Grasemann, H; Ratjen, F; Reutershahn, E; Schnabel, D; Vester, U, 2008) |
| "In CF airways MPO acts as a phagocyte-derived NO oxidase that diminishes NO bioavailability at airway surfaces, possibly identifying this peroxidase as a potential target for therapeutic intervention." | 1.36 | Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway. ( Chapman, AL; Cross, CE; Eiserich, JP; Houghton, JS; Juarez, MM; Li, CS; Morrissey, BM; Vasu, VT, 2010) |
| "The role of these factors in the pulmonary disease associated with cystic fibrosis is not clear." | 1.28 | Pathogenic factors of Pseudomonas cepacia isolates from patients with cystic fibrosis. ( Gessner, AR; Mortensen, JE, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.33) | 18.7374 |
| 1990's | 7 (23.33) | 18.2507 |
| 2000's | 11 (36.67) | 29.6817 |
| 2010's | 8 (26.67) | 24.3611 |
| 2020's | 3 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galiniak, S | 1 |
| Rohovyk, N | 1 |
| Rachel, M | 1 |
| Jabalameli, F | 1 |
| Emaneini, M | 1 |
| Beigverdi, R | 1 |
| Halimi, S | 1 |
| Siroosi, M | 1 |
| Martin, LW | 1 |
| Gray, AR | 1 |
| Brockway, B | 1 |
| Lamont, IL | 1 |
| McCaughey, G | 1 |
| Gilpin, DF | 1 |
| Schneiders, T | 1 |
| Hoffman, LR | 1 |
| McKevitt, M | 1 |
| Elborn, JS | 1 |
| Tunney, MM | 1 |
| Fila, L | 1 |
| Chladek, J | 1 |
| Maly, M | 1 |
| Musil, J | 1 |
| Kolpen, M | 2 |
| Kühl, M | 2 |
| Bjarnsholt, T | 2 |
| Moser, C | 1 |
| Hansen, CR | 2 |
| Liengaard, L | 1 |
| Kharazmi, A | 1 |
| Pressler, T | 1 |
| Høiby, N | 2 |
| Jensen, PØ | 2 |
| Kragh, KN | 1 |
| Line, L | 1 |
| Dalbøge, CS | 1 |
| Hansen, N | 1 |
| Greguš, M | 1 |
| Foret, F | 1 |
| Kindlová, D | 1 |
| Pokojová, E | 1 |
| Plutinský, M | 1 |
| Doubková, M | 1 |
| Merta, Z | 1 |
| Binková, I | 1 |
| Skřičková, J | 1 |
| Kubáň, P | 1 |
| Fowler, RC | 1 |
| Hanson, ND | 1 |
| Kerley, CP | 1 |
| Kilbride, E | 1 |
| Greally, P | 1 |
| Elnazir, B | 1 |
| Zetterquist, W | 1 |
| Marteus, H | 1 |
| Kalm-Stephens, P | 1 |
| Näs, E | 1 |
| Nordvall, L | 1 |
| Johannesson, M | 1 |
| Alving, K | 1 |
| Palop-Cervera, M | 1 |
| de Diego Damiá, A | 1 |
| Martínez-Moragón, E | 1 |
| Cortijo, J | 1 |
| Fullana, J | 1 |
| León, M | 1 |
| Chapman, AL | 1 |
| Morrissey, BM | 2 |
| Vasu, VT | 1 |
| Juarez, MM | 1 |
| Houghton, JS | 1 |
| Li, CS | 1 |
| Cross, CE | 2 |
| Eiserich, JP | 2 |
| Schilling, K | 1 |
| Weil, JV | 1 |
| Silkoff, PE | 1 |
| Rodman, DM | 1 |
| Latzin, P | 1 |
| Beck, J | 1 |
| Bartenstein, A | 1 |
| Griese, M | 1 |
| Palmer, KL | 1 |
| Brown, SA | 1 |
| Whiteley, M | 1 |
| Grasemann, C | 1 |
| Ratjen, F | 2 |
| Schnabel, D | 1 |
| Reutershahn, E | 1 |
| Vester, U | 1 |
| Grasemann, H | 3 |
| Platt, MD | 1 |
| Schurr, MJ | 1 |
| Sauer, K | 1 |
| Vazquez, G | 1 |
| Kukavica-Ibrulj, I | 1 |
| Potvin, E | 1 |
| Levesque, RC | 1 |
| Fedynak, A | 1 |
| Brinkman, FS | 1 |
| Schurr, J | 1 |
| Hwang, SH | 1 |
| Lau, GW | 1 |
| Limbach, PA | 1 |
| Rowe, JJ | 1 |
| Lieberman, MA | 1 |
| Barraud, N | 1 |
| Webb, J | 1 |
| Kjelleberg, S | 1 |
| Hunt, DF | 1 |
| Hassett, DJ | 1 |
| Robroeks, CM | 1 |
| Rosias, PP | 1 |
| van Vliet, D | 1 |
| Jöbsis, Q | 1 |
| Yntema, JB | 1 |
| Brackel, HJ | 1 |
| Damoiseaux, JG | 1 |
| den Hartog, GM | 1 |
| Wodzig, WK | 1 |
| Dompeling, E | 1 |
| Ioannidis, I | 1 |
| Tomkiewicz, RP | 1 |
| de Groot, H | 1 |
| Rubin, BK | 1 |
| Linnane, SJ | 1 |
| Keatings, VM | 1 |
| Costello, CM | 1 |
| Moynihan, JB | 1 |
| O'Connor, CM | 1 |
| Fitzgerald, MX | 1 |
| McLoughlin, P | 1 |
| Kelley, TJ | 1 |
| Drumm, ML | 1 |
| Jones, KL | 1 |
| Hegab, AH | 1 |
| Hillman, BC | 1 |
| Simpson, KL | 1 |
| Jinkins, PA | 1 |
| Grisham, MB | 1 |
| Owens, MW | 1 |
| Sato, E | 2 |
| Robbins, RA | 2 |
| Van Der Vliet, A | 1 |
| Nguyen, MN | 1 |
| Shigenaga, MK | 1 |
| Marelich, GP | 1 |
| Hadeli, K | 1 |
| Nelson, D | 1 |
| Hoyt, JC | 1 |
| Tabcharani, JA | 1 |
| Chang, XB | 1 |
| Riordan, JR | 1 |
| Hanrahan, JW | 1 |
| Rich, DP | 1 |
| Gregory, RJ | 1 |
| Anderson, MP | 1 |
| Manavalan, P | 1 |
| Smith, AE | 1 |
| Welsh, MJ | 1 |
| Gessner, AR | 1 |
| Mortensen, JE | 1 |
| Chernick, WS | 1 |
1 review available for nitrates and Cystic Fibrosis
| Article | Year |
|---|---|
Nitric oxide, peroxynitrite, and lower respiratory tract inflammation.
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Cystic Fibrosis; Eosinophils; Humans; Nitrates; Nitri | 2000 |
2 trials available for nitrates and Cystic Fibrosis
| Article | Year |
|---|---|
Comparison of exhaled breath condensate from nasal and oral collection.
Topics: Adult; Biomarkers; Breath Tests; Child; Cystic Fibrosis; Exhalation; Humans; Hydrogen Peroxide; Mout | 2003 |
Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients.
Topics: Adolescent; Child; Cystic Fibrosis; Double-Blind Method; Human Growth Hormone; Humans; Nitrates; Nit | 2008 |
27 other studies available for nitrates and Cystic Fibrosis
| Article | Year |
|---|---|
Biomarkers of nitrosative stress in exhaled breath condensate and serum among patients with cystic fibrosis.
Topics: Biomarkers; Breath Tests; Cystic Fibrosis; Humans; Nitrates; Nitrites; Nitrosative Stress | 2023 |
Determining effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of clinical strains of Pseudomonas aeruginosa in biofilm-inspired alginate encapsulates.
Topics: Alginates; Amikacin; Anti-Bacterial Agents; Arginine; Biofilms; Ciprofloxacin; Cystic Fibrosis; Huma | 2023 |
Pseudomonas aeruginosa is oxygen-deprived during infection in cystic fibrosis lungs, reducing the effectiveness of antibiotics.
Topics: Anti-Bacterial Agents; Cystic Fibrosis; Humans; Lung; Microbial Sensitivity Tests; Nitrates; Oxygen; | 2023 |
Fosfomycin and tobramycin in combination downregulate nitrate reductase genes narG and narH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacterial Proteins; Cystic Fibrosis; Drug Combinations; Fosfomy | 2013 |
Nitrites and nitrates in exhaled breath condensate in cystic fibrosis: relation to clinical parameters.
Topics: Adolescent; Adult; Breath Tests; Cystic Fibrosis; Female; Humans; Male; Nitrates; Nitrites; Young Ad | 2013 |
Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection.
Topics: Adult; Biosensing Techniques; Chronic Disease; Cystic Fibrosis; Demography; Female; Humans; Male; Mi | 2014 |
Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
Topics: Achromobacter denitrificans; Adolescent; Adult; Anaerobiosis; Bacterial Load; Burkholderia cepacia c | 2015 |
Monitoring the ionic content of exhaled breath condensate in various respiratory diseases by capillary electrophoresis with contactless conductivity detection.
Topics: Acetates; Adult; Aged; Ammonium Compounds; Asthma; Breath Tests; Butyrates; Calcium; Chlorides; Crow | 2015 |
The OpdQ porin of Pseudomonas aeruginosa is regulated by environmental signals associated with cystic fibrosis including nitrate-induced regulation involving the NarXL two-component system.
Topics: Bacterial Proteins; Cystic Fibrosis; Gene Expression Regulation, Bacterial; Humans; Nitrates; Porins | 2015 |
Dietary Nitrate Acutely and Markedly Increased Exhaled Nitric Oxide in a Cystic Fibrosis Case.
Topics: Arginine; Child; Cystic Fibrosis; Diet; Exhalation; Humans; Inflammation; Iron; Male; Nitrates; Nitr | 2016 |
Oral bacteria--the missing link to ambiguous findings of exhaled nitrogen oxides in cystic fibrosis.
Topics: Adolescent; Adult; Bacteria; Breath Tests; Child; Chlorhexidine; Cystic Fibrosis; Exhalation; Female | 2009 |
[Inflammation markers in the exhaled air of patients with bronchiectasis unassociated with cystic fibrosis].
Topics: Biomarkers; Breath Tests; Bronchiectasis; C-Reactive Protein; Cystic Fibrosis; Dinoprost; Female; Hu | 2009 |
Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway.
Topics: Adult; Biological Availability; Breath Tests; Cystic Fibrosis; Exhalation; Female; Humans; Hydrogen | 2010 |
Nitric oxide and protein nitration in the cystic fibrosis airway.
Topics: Adult; Aged; Analysis of Variance; Cystic Fibrosis; Female; Humans; Male; Middle Aged; Nitrates; Nit | 2002 |
Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum.
Topics: Anaerobiosis; Artificial Gene Fusion; Bacterial Proteins; Base Sequence; beta-Galactosidase; Colony | 2007 |
Proteomic, microarray, and signature-tagged mutagenesis analyses of anaerobic Pseudomonas aeruginosa at pH 6.5, likely representing chronic, late-stage cystic fibrosis airway conditions.
Topics: Anaerobiosis; Bacteriophage Pf1; Cystic Fibrosis; DNA Transposable Elements; Electrophoresis, Gel, T | 2008 |
Biomarkers in exhaled breath condensate indicate presence and severity of cystic fibrosis in children.
Topics: Adolescent; Biomarkers; Breath Tests; Child; Cross-Sectional Studies; Cystic Fibrosis; Cytokines; Di | 2008 |
Nitric oxide metabolites in cystic fibrosis lung disease.
Topics: Adolescent; Adult; Biomarkers; Child; Cystic Fibrosis; Forced Expiratory Volume; Humans; Middle Aged | 1998 |
Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis.
Topics: Acute Disease; Adult; Breath Tests; Cystic Fibrosis; Disease Progression; Female; Humans; Male; Nitr | 1998 |
Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells.
Topics: Amiloride; Animals; Biological Transport; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance | 1998 |
Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis.
Topics: Acute Disease; Biomarkers; Breath Tests; Cystic Fibrosis; Humans; Nitrates; Nitric Oxide; Nitrites; | 1999 |
Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum.
Topics: Adolescent; Adult; Cystic Fibrosis; Female; Free Radicals; Humans; Inflammation; Male; Nitrates; Nit | 2000 |
Myeloperoxidase and protein oxidation in cystic fibrosis.
Topics: Adult; Bronchi; Case-Control Studies; Cell Line; Chromatography, High Pressure Liquid; Cystic Fibros | 2000 |
The cystic fibrosis transmembrane conductance regulator chloride channel. Iodide block and permeation.
Topics: Animals; Biophysical Phenomena; Biophysics; Cell Membrane Permeability; Chloride Channels; CHO Cells | 1992 |
Effect of deleting the R domain on CFTR-generated chloride channels.
Topics: Binding Sites; Chloride Channels; Chlorides; Cyclic AMP; Cystic Fibrosis; Cystic Fibrosis Transmembr | 1991 |
Pathogenic factors of Pseudomonas cepacia isolates from patients with cystic fibrosis.
Topics: Amino Acids; Catalase; Cystic Fibrosis; Cytotoxins; Endopeptidases; Glycoside Hydrolases; Hemolysis; | 1990 |
Pharmacological aspects of submaxillary gland secretion in cystic fibrosis.
Topics: Adult; Autonomic Nervous System; Bretylium Compounds; Calcium; Child; Cystic Fibrosis; Fucose; Guane | 1968 |